|
|
 |
|
|
Pharmasol - News
|
PharmaSol decided to introduce a new section on its homepage (start:
1st January 2004) to inform cooperation partners and potential share buyers about the company´s activities and performance.
World-wide exclusive licensing agreement for NLC.
Nanostructured Lipid Carrier, NLC, developed by R. H. Müller, PharmaSol
GmbH, is a novel carrier generation for controlled drug delivery. CLR -
Chemisches Laboratorium Dr. Kurt Richter GmbH has acquired the worldwide
license for production and distribution of NLC loaded with actives for
cosmetic use.
The license is limited for intermediate products (excipients) to be
processed further to final market products. An exclusive world-wide license
for further products is still available, apart from Germany, Switzerland and
Austria.
9-11 May 2004 - PharmaSol at TCI Conference in Reston/VA
The company, Technology Catalysts, is arranging its annual technology
transfer meeting. The "21st Annual International Technology Transfer
Forum" will take place near Washington, D.C. in Reston/VA from 9-11
May (www.technology-catalysts.com). PharmaSol will present two
presentations, one on Monday morning (10 May) "Drug nanocrystals for
formulation of poorly soluble drugs" and another on Tuesday morning (11
May) "Lipid nanoparticles for drug delivery".
4 May 2004 - "Scientific Oskar" for PharmaSol technology
Each year the German company BSB and Dr. Riedel Verlag/Hamburg awards
an "Oskar" for outstanding development in the area of cosmetic
excipients. This year the Oskar was awarded to Prof. Rainer H.
Müller/PharmaSol GmbH for his developments in the area of lipid
nanoparticles, that is solid lipid nanoparticles (SLN) and
nanostructured lipid carriers (NLC).
The price committee consisted of representatives from the companies Beiersdorf, Lever-Fabergé and L’Oreal.
Mr. Robert Fischer from the Journal SÖFW represented the press. Karl Raabe was the German IFSCC representative.
The Oskar will be awarded to Prof.
Müller in Tannhausen/Augsburg in South Germany on 4 May 2004. BSB is a
company that holds seminars about cosmetic topics, and two seminars recorded by Prof.
Müller about the use of lipid nanoparticles in cosmetics can be ordered by going to:
www.bsb-cosmetic.de.
11 February 2004 - PharmaSol and SPQR GmbH
PharmaSol announces a cooperation agreement with SPQR GmbH for joint
development of a new formulation for pain treatment in cancer patients.
The formulation will be based on a new concept to treat patients during
acute pain attacks.
2 January 2004 - New company profile for PharmaSol
PharmaSol decided to re-structure its drug delivery activities and focus on the area of poorly soluble drugs.
The major target will be to increase the solubility of drugs to enable sufficiently high bioavailability after
oral administration or dermal application, or alternatively to produce i. v. injectable formulations. The new
mission of the company will be "PharmaSol - the solubility people", and the main proprietary technologies used
are the drug nanocrystals (Nanopure®) and the lipid nanoparticles - nanostructured lipid carriers (NLC®).
Other technologies, such as the brain targeting delivery system (PathFinder®), the stable biocompatible adjuvant
(SBA) for vaccines and
the cosmetic IP (Nanopearls for the delivery of cosmetic actives and
formulation of sunscreens), are for sale.
|
|
